Secondary cardiovascular prevention after acute coronary syndrome: emerging risk factors and novel therapeutic targets

A Silverio, FP Cancro, L Esposito, M Bellino… - Journal of Clinical …, 2023 - mdpi.com
The control of cardiovascular risk factors, the promotion of a healthy lifestyle, and
antithrombotic therapy are the cornerstones of secondary prevention after acute coronary …

Medical Therapy for Long-Term Prevention of Atherothrombosis Following an Acute Coronary Syndrome: JACC State-of-the-Art Review

G Gallone, L Baldetti, M Pagnesi, A Latib… - Journal of the American …, 2018 - jacc.org
Following an acute coronary syndrome (ACS), heightened predisposition to
atherothrombotic events may persist for years. Advances in understanding the pathobiology …

Gut microbiota and acute coronary syndromes: ready for use in the emergency room?

M Trøseid - European heart journal, 2017 - academic.oup.com
The gut microbiota, comprising the trillions of bugs inhabiting the gastrointestinal tract, may
be considered a complex bioreactor with several metabolic and immunological effects that …

The gut microbiome across the cardiovascular risk spectrum

FM Prins, V Collij, HE Groot, JR Björk… - European Journal of …, 2024 - academic.oup.com
Aims Despite treatment advancements, cardiovascular disease remains a leading cause of
death worldwide. Identifying new targets is crucial for enhancing preventive and therapeutic …

Lipoproteins as biomarkers and therapeutic targets in the setting of acute coronary syndrome

RS Rosenson, HB Brewer, DJ Rader - Circulation research, 2014 - Am Heart Assoc
The period following an acute coronary syndrome (ACS) represents a critical time frame with
a high risk for recurrent events and death. The pathogenesis of this increase in clinical …

Appropriateness of dyslipidemia management strategies in post-acute coronary syndrome: a 2023 update

F Lucà, F Oliva, CM Rao, MG Abrignani, AF Amico… - Metabolites, 2023 - mdpi.com
It has been consistently demonstrated that circulating lipids and particularly low-density
lipoprotein cholesterol (LDL-C) play a significant role in the development of coronary artery …

Myocardial infarction and gut microbiota: an incidental connection

SZ Vahed, A Barzegari, M Zuluaga, D Letourneur… - Pharmacological …, 2018 - Elsevier
Myocardial infarction (MI) is the main cause of cardiovascular crises that entails serious
concerns in mortality, morbidity, and cost to the society. The main therapeutic goal of modern …

Association of lipoprotein (a) with risk of recurrent ischemic events following acute coronary syndrome: analysis of the dal-outcomes randomized clinical trial

GG Schwartz, CM Ballantyne, PJ Barter… - JAMA …, 2018 - jamanetwork.com
Importance It is uncertain whether lipoprotein (a)[Lp (a)], which is associated with incident
cardiovascular disease, is an independent risk factor for recurrent cardiovascular events …

Role of gut microbiota in cardiovascular diseases–a comprehensive review

S Rashid, AI Sado, MS Afzal, A Ahmed… - Annals of Medicine …, 2024 - journals.lww.com
The connection between cardiovascular illnesses and the gut microbiota has drawn more
and more attention in recent years. According to research, there are intricate relationships …

[HTML][HTML] Update to evidence-based secondary prevention strategies after acute coronary syndrome

DH Fitchett, LA Leiter, P Lin, J Pickering, R Welsh… - CJC open, 2020 - Elsevier
A recent acute coronary syndrome provides an opportunity to optimise secondary prevention
strategies to reduce the risk of future cardiovascular events. This review provides an …